Deborah McCloskey

Intravenous iloprost treatment of Raynaud's phenomenon and ischemic ulcers secondary to systemic sclerosis.

Fred Wigley, James R. Seibold, Robert A. Wise et al. · PubMed · 1992 · 201 citations

Medicine, Internal Medicine, Pharmacotherapy +11

Randomized Placebo-Controlled Crossover Trial of Tadalafil in Raynaud’s Phenomenon Secondary to Systemic Sclerosis

Elena Schiopu, Vivien Hsu, Ann Impens et al. · The Journal of Rheumatology · 2009 · 105 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +12

Pain, Analgesic Use, and Patient Satisfaction With Spinal Versus General Anesthesia for Hip Fracture Surgery

Mark D. Neuman, Rui Feng, Susan S. Ellenberg et al. · Annals of Internal Medicine · 2022 · 58 citations

Medicine, Orthopedic Surgery, Surgery +15

Safety and pharmacokinetics of recombinant human relaxin in systemic sclerosis.

James R. Seibold, Philip J. Clements, Daniel E. Fürst et al. · PubMed · 1998 · 46 citations

Medicine, Pharmacokinetics, Pharmacology +9

Bosentan in pulmonary arterial hypertension secondary to scleroderma.

Amit Joglekar, Fausan S. Tsai, Deborah McCloskey et al. · PubMed · 2006 · 41 citations

Medicine, Cardiology, Pharmacotherapy +12